GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.39

Change

+0.13 (+1.79)%

Market Cap

N/A

Volume

0.43M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+1.00 (+0.69%)

USD 92.95B
VTR Ventas Inc

+0.38 (+0.56%)

USD 29.24B
DOC Healthpeak Properties Inc

+0.06 (+0.32%)

USD 14.30B
CTRE CareTrust REIT Inc.

+0.16 (+0.57%)

USD 5.43B
AHR American Healthcare REIT, Inc.

+0.42 (+1.40%)

USD 4.79B
NHI National Health Investors Inc

+0.63 (+0.85%)

USD 3.43B
LTC LTC Properties Inc

+0.31 (+0.89%)

USD 1.55B
UHT Universal Health Realty Income..

+0.36 (+0.95%)

USD 0.58B
CHCT Community Healthcare Trust Inc

+0.09 (+0.58%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

+0.10 (+0.41%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 0.00 % 0.35 %

+0.11 (+0%)

USD 0.22B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.27% 27% F 55% F
Dividend Return 2.72% 100% F 90% A-
Total Return -1.55% 33% F 65% D
Trailing 12 Months  
Capital Gain -7.39% 13% F 29% F
Dividend Return 10.53% 100% F 95% A
Total Return 3.13% 13% F 47% F
Trailing 5 Years  
Capital Gain -30.09% 38% F 12% F
Dividend Return 39.26% 77% C+ 80% B-
Total Return 9.18% 38% F 25% F
Average Annual (5 Year Horizon)  
Capital Gain -5.71% 33% F 12% F
Dividend Return 1.12% 33% F 29% F
Total Return 6.83% 87% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.11% 47% F 43% F
Risk Adjusted Return 4.64% 33% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.